Gynecologic Cancer
Gynecologic Oncology Consult
The perils of CA-125 as a diagnostic tool in patients with adnexal masses
It is important to have conversations with patients before ordering a CA-125 (or other serum biomarkers) about potential results and their effect...
Latest News
Sexual minorities less likely to receive Pap screening
“This is very concerning, as cervical-cancer screening can catch this disease at early stages to prevent poor outcomes.”
Latest News
Imiquimod cream offers alternative to surgery for vulvar lesions
Good patient compliance is important for treatment with imiquimod to be successful and that surgery might remain the treatment of choice for...
Clinical Review
2022 Update on cervical disease
Cervical cancer screening is transitioning from Pap cytology to primary human HPV testing. Are we ready? These experts review...
Clinical Review
Cervical cancer: A path to eradication
“…in the next generation or two, we seriously might eradicate not just cervical cancer but a lot of HPV-related malignancies...
Expert Commentary
Can US “pattern recognition” of classic adnexal lesions reduce surgery, and even referrals for other imaging, in average-risk women?
This is not a new concept. Numerous studies1 have found that pattern recognition performed as well or better...
Latest News
Topical imiquimod as good as surgery for vulvar intraepithelial neoplasia
“The oncological safety of imiquimod treatment can be assumed as long as regular clinical check-ups are carried out.”
From the Journals
Three symptoms suggest higher risk for self-injury in cancer
“Self-injury can be a means to cope with psychological difficulties for some patients, without intent for suicide.”
Gynecologic Oncology Consult
Hormones after cancer: Are they safe?
Hormonal therapy is safe, even beneficial, for many patients with a history of gynecologic cancer, and can significantly improve their quality of...
Feature
Cheap and noninvasive: Detecting HPV in sanitary pads
“There is a critical need for new strategies to reach this population. We absolutely have to do something out of the box creatively.”
From the Journals
First-recorded treatment of pregnant lymphoma patient with checkpoint inhibitor
A pregnant lymphoma patient was treated successfully with an immune checkpoint inhibitor, the first such case reported in medical literature.